Elyxium Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Elyxium Wealth’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$29.9K	Buy	+498	New	+$31.4K	﹤0.01%	753

Other funds holding BMRN

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Covea Finance Paris, France $3.07B AUM 27.46% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Elyxium Wealth's BMRN Position: Q3 2026 in Review

Elyxium Wealth opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 498 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #753 among its holdings.

155 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

Elyxium Wealth held 498 shares of BioMarin Pharmaceuticals worth $29.9K as of Q3 2026.
BioMarin Pharmaceuticals was a new Elyxium Wealth position in Q3 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #753 holding.
155 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.